Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: PolyMedica Industries

This article was originally published in The Gray Sheet

Executive Summary

PolyMedica Industries: Inks letter of intent to acquire the assets of Liberty Medical Supply for cash and notes valued at about $9 mil. Privately-held Liberty, which distributes diabetes testing supplies and medical products, expects sales of over $13 mil. in 1996. The acquisition would provide Woburn, Massachusetts-based wound dressings firm PolyMedica "the opportunity for rapid expansion into the large and receptive diabetic market," PolyMedica says...

You may also be interested in...



PolyMedica Accounting Practice Draws Shareholder Class Action Suits

PolyMedica will change its accounting practices after discussions with the Securities & Exchange Commission over the method the firm employs to capitalize its advertising costs

What Lies Ahead: COVID-19 Vaccination Challenges

The director of adult immunizations at Johns Hopkins International Vaccine Access Center talks to Scrip about undertaking a massive COVID-19 vaccination effort in the US.

UsernamePublicRestriction

Register

OM006664

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel